Orphinic Scientific S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-09-03
Share capital
506,090.90 PLN
Activity description

Orphinic Scientific is a biopharma holding focused on the clinical development of projects in therapeutics, MedTech and e-Health. Its portfolio includes an enhanced analgesic formulation, a therapeutic mechanism for diastolic heart failure, and a software solution designed to automate clinical trial monitoring. The company verifies research hypotheses through clinical trials and partners or transacts assets with pharmaceutical players.

Registered address
ul. Stanisława Żaryna 2B, 02-593 Warszawa, Poland
Email
Phone
Electronic delivery address
AE:PL-12967-28260-CUWDC-20

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 97 days late). All were audited by a statutory auditor.

  • 2025filed
  • 202404/07/2025
  • 202310/07/2024
  • 202213/07/2023
  • 202120/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,116 / 1,943
Top 57%
City · Warszawa41,709 / 56,729
Top 74%
Voivodeship · Mazowieckie57,695 / 76,892
Top 75%
Country · Poland227,685 / 297,069
Top 77%

Results vs industry

Revenue
This companyUSD 42.97kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -969.47kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 360.96kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 10.99mMedianUSD 134.71kAverageUSD 3.04m

Offer

Websites

Job offers

The company lists 2 job openings on its own careers page: orphinic.com/career.

Position
Associate Financial Modelling and Stock Market
Associate Financial Modelling and Stock Market

Authorized Representatives

Agnieszka Pogorzelska age 47 – Attorney-in-fact (joint)
Artur Płonowski age 61 – Management Board Member
Wojciech Jacek Ciesielski age 44 – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented by the sole member of the management board. If the management board is multi-member, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations of will and sign on behalf of the company.

Supervisory board

Adam Kruszewski age 61 – Supervisory Board Member
Wiesław Jacenty Drópiewski age 61 – Supervisory Board Member
Paweł Grzegorz Leks age 50 – Supervisory Board Member
Piotr Radosław Hammer age 60 – Supervisory Board Member
Jarosław Jerzy Leszczyszyn age 65 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
DEBN sp. z o.o.
44.0313%
Tramag sp. z o.o.
59.0504%
VM1 sp. z o.o.
100%

Bank accounts

Registered as a VAT taxpayer on 2020-09-01.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Apr 11, 2025Commercial Companies Code notice
Sep 2, 2024Commercial Companies Code notice

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Change history

DateEvent
2026-04-09Address change
2026-04-09Share capital increase
2025-04-28Share capital increase
2025-02-18Share capital increase
2024-12-11Share capital increase

FAQ

Last updated: 2026-04-09